The results manifested that plasma Circ-CUL2 was extremely linked with clinical stage and lymph node metastasis, assuring that CirC-CUL2 was supposed to be a biomarker for NSCLC diagnosis and prognosis. This evidence concerns the gene CUL2 and non-small cell lung carcinoma.